OriGene Logo

Customer Login

Checkout as a new customer

Creating an account has many benefits:

  • See order and shipping status
  • Track order history
  • Check out faster
Create an Account

TissueScan, Kidney Cancer cDNA Array II

Be the first to review this product
SKU
HKRT102
48 samples covering 9-normal, 10-Stage I, 5-II, 13-III, 11-IV. Available in 2, 5, 10 identical plates.
  $1,060.00
2 Weeks*

Frequently Bought Together (4)

D11-18 Polink-1 HRP Polymer Detection for MOUSE and RABBIT antibodies on human tissue
18 ml
$420.00
D12-6 Polink-1 HRP Polymer Detection for MOUSE antibody on human or animal tissue (non-rodent)
6 ml
$250.00
HP205798 qSTAR qPCR primer pairs against Homo sapiens gene GAPDH 200 reactions
$150.00
MP205604 qSTAR qPCR primer pairs against Mus musculus gene Gapdh 200 reactions
$150.00
Specifications
Specifications
Product Data
TissueScan Type Cancer Specific
Array Name Kidney Cancer cDNA Array II
Clinical Info
Diagnosis Category Kidney Cancer
Tissue Kidney
Shipping Ambient
Description 48 samples covering 9-normal, 10-Stage I, 5-II, 13-III, 11-IV. Available in 2, 5, 10 identical plates.
Reviews
Write Review
 
 
 
 
 

Be the first to review this product

Please note:
Only reviews with images are eligible for a $20/20€ Amazon gift card.
Reviews without images are eligible for a $10/10€ Amazon gift card.
For more details about the terms and conditions, please visit the promotion page.

Review image
Documents
Resources

file-alt Citations

HOTAIRM1 lncRNA is downregulated in clear cell renal cell carcinoma and inhibits the hypoxia pathway
Hamilton, Young, Jang et al
Cancer Lett. (2019) 472, 50-58 DOI: 10.1016/j.canlet.2019.12.022
Cited by 88
AI Summary: OriGene contributed 12 ccRCC tumor/normal matched pair RNA samples and multiple human tissue cDNA arrays (CSRT301, HKRT102) that were used to analyze HOTAIRM1 expression in the study.
Snippet: … The multiple human tissue cDNA arrays were obtained from Origene (CSRT301, HKRT102) and were normalized to ACTB;;- The 12 ccRCC tumor/normal matched pair RNA samples were obtained from Origene (see Supplemental Information). The multiple human tissue cDNA arrays were obtained from Origene (CSRT301, HKRT102) and were normalized to ACTB
Targeting the vasopressin type-2 receptor for renal cell carcinoma therapy
Sinha, Dwivedi, Tao et al
Oncogene (2019) 39 (6), 1231-1245 DOI: 10.1038/s41388-019-1059-0
AI Summary: OriGene’s human cDNA array (#HKRT102) was used to assess V2R expression in various kidney and renal cell carcinoma tissue samples via RT-PCR, contributing to the study’s analysis of V2R activity in RCC.
Snippet: A human cDNA array (#HKRT102) consisting of cDNA from 9 control nontumor kidney tissue, 27 ccRCC, and 12 papillary RCC was purchased from OriGene, Rockville, MD. RT-PCR was carried out as following the manufacturer’s instructions, and samples were run on 2% agarose gels
miR-1267 Induces Tumorigenicity and Contributes to Risk of Clear Cell Renal Cell Carcinoma
Ergün, Konanç
Middle Black Sea Journal of Health Science (2019)
Snippet: Methods In this study, Kidney Cancer cDNA Array (Origene Technologies Inc., Rockville, MD, USA) consisting of cDNA samples obtained from healthy kidney tissues of 4 healthy individuals and tumoral kidney tissues of 5 Stage I, 5 Stage II, 3 Stage III and 2 Stage IV View as HTML
Tr-KIT/c-KIT ratio in renal cell carcinoma
Ergün, Altay, Güneş et al
Mol. Biol. Rep. (2019)
AI Summary: OriGene's Kidney Cancer cDNA Array was used in this study to provide kidney tumor and normal tissue cDNA samples for gene expression analysis of tr-KIT and c-KIT in renal cell carcinoma.
Snippet: Materials and methods Study subjects In this study, Kidney Cancer cDNA Array (Origene Tech- nologies Inc., Rockville, MD, USA), a commercially avail- able, ready-to-use RCC cDNA panel for gene expression analysis using Real-Time PCR, was used [17]
Fluorocholine transport mediated by the organic cation transporter 2 (OCT2,SLC22A2): implication for imaging of kidney tumors
Visentin, Torozi, Gai et al
Drug Metab. Dispos. (2018)
AI Summary: OriGene contributed to this study by providing commercially available cDNA samples (TissueScan Kidney Cancer cDNA) used to assess SLC22A2 (OCT2) mRNA expression levels in kidney cancer tissues.
Snippet: characteristics are available in table 1. cDNA samples used for the assessment of SLC22A2 mRNA expression level was commercially available from Origene (Rockville, MD) (https://www.origene.com/catalog/tissues/tissuescan/hkrt102/tissuescan-kidney- cancer-cdna View as HTML
Ankyrin repeat and Single KH domain 1 (ANKHD1) drives renal cancer cell proliferation via binding to and altering a subset of miRNAs
Fragiadaki, Zeidler
J. Biol. Chem. (2018) 293 (25), 9570-9579 DOI: 10.1074/jbc.RA117.000975
AI Summary: OriGene’s Kidney Cancer Tissue qPCR array (HKRT102) was used to measure ANKHD1 and miR-29a mRNA levels in human RCC patient and healthy control samples, enabling the authors to assess gene expression differences relevant to cancer proliferation.
Snippet: To study the mRNA levels of ANKHD1 or miR29a in human RCC patients and healthy controls a tissue scan Kidney Cancer Tissue qPCR array was used (Origene, HKRT102), and qPCR was performed following manufacturer's instructions (using primers stated above
Showing 1-6 of 7 papers.
Powered by BizGenius
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Related Products